Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.
Ang CW, Nedjadi T, Sheikh AA, Tweedle EM, Tonack S, Honap S, Jenkins RE, Park BK, Schwarte-Waldhoff I, Khattak I, Azadeh B, Dodson A, Kalirai H, Neoptolemos JP, Rooney PS, Costello E. Ang CW, et al. Among authors: honap s. Carcinogenesis. 2010 Sep;31(9):1541-51. doi: 10.1093/carcin/bgq137. Epub 2010 Jul 9. Carcinogenesis. 2010. PMID: 20622003
Vedolizumab-Associated Drug-Induced Liver Injury: A Case Series.
Honap S, Sticova E, Theocharidou E, Berry P, Irving PM, Samaan MA, Kotha S. Honap S, et al. Inflamm Bowel Dis. 2021 Feb 16;27(3):e32-e34. doi: 10.1093/ibd/izaa286. Inflamm Bowel Dis. 2021. PMID: 33155638 No abstract available.
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
Kennedy NA, Goodhand JR, Bewshea C, Nice R, Chee D, Lin S, Chanchlani N, Butterworth J, Cooney R, Croft NM, Hart AL, Irving PM, Kok KB, Lamb CA, Limdi JK, Macdonald J, McGovern DP, Mehta SJ, Murray CD, Patel KV, Pollok RC, Raine T, Russell RK, Selinger CP, Smith PJ, Bowden J, McDonald TJ, Lees CW, Sebastian S, Powell N, Ahmad T; Contributors to the CLARITY IBD study. Kennedy NA, et al. Gut. 2021 May;70(5):865-875. doi: 10.1136/gutjnl-2021-324388. Epub 2021 Mar 22. Gut. 2021. PMID: 33753421
Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal response.
Samaan MA, Birdi S, Morales MS, Honap S, Tamilarasan AG, Cunningham G, Koumoutsos I, Ray S, Mawdsley J, Anderson SHC, Sanderson J, Irving PM. Samaan MA, et al. Among authors: honap s. Frontline Gastroenterol. 2019 Jul 11;11(3):188-193. doi: 10.1136/flgastro-2019-101259. eCollection 2020. Frontline Gastroenterol. 2019. PMID: 32419909 Free PMC article.
5-ASAs in Crohn's Disease: Time to Stop the Salicylate?
Honap S, Sharma E, Samaan MA. Honap S, et al. Dig Dis Sci. 2022 Jul;67(7):2699-2700. doi: 10.1007/s10620-021-07304-8. Epub 2021 Nov 19. Dig Dis Sci. 2022. PMID: 34797441 No abstract available.
49 results